K-RAS Produits
(GTPase Kras (KRAS))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories K-RAS en vedette
K-RAS Anticorps
High quality antibodies with extensive validation data.
K-RAS Kits ELISA
Reliable ELISA kits for a wide range of species.
K-RAS Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
K-RAS recommandé Anticorps
- (5)
- (5)
- (1)
- (4)
- (7)
K-RAS recommandé Kits ELISA
- (1)
- (1)
K-RAS recommandé Protéines
- (1)
- (1)
- (1)
Dernières publications sur nos produits K-RAS
: "EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells." dans: Acta pharmacologica Sinica, Vol. 41, Issue 2, pp. 270-277, (2020) (PubMed).: "Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations." dans: Cancer research, Vol. 76, Issue 3, pp. 675-85, (2016) (PubMed).
: "Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10." dans: Oncotarget, Vol. 7, Issue 30, pp. 47720-47737, (2016) (PubMed).
: "Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells." dans: Cell cycle (Georgetown, Tex.), Vol. 14, Issue 11, pp. 1686-97, (2015) (PubMed).
: "Evidence for aldosterone-dependent growth of renal cell carcinoma." dans: International journal of experimental pathology, Vol. 95, Issue 4, pp. 244-50, (2014) (PubMed).
: "Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells." dans: Molecular cancer therapeutics, Vol. 13, Issue 8, pp. 2073-80, (2014) (PubMed).
: "KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. ..." dans: International journal of cancer. Journal international du cancer, Vol. 133, Issue 5, pp. 1259-65, (2013) (PubMed).
: "4-Hydroxytamoxifen induces autophagic death through K-Ras degradation." dans: Cancer research, Vol. 73, Issue 14, pp. 4395-405, (2013) (PubMed).
: "Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells." dans: PLoS ONE, Vol. 7, Issue 12, pp. e51449, (2012) (PubMed).
: "Analysis of k-ras nuclear expression in fibroblasts and mesangial cells." dans: PLoS ONE, Vol. 5, Issue 1, pp. e8703, (2010) (PubMed).
Synonymes et noms alternatifs relatifs à K-RAS
KRAS proto-oncogene, GTPase (KRAS), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (kras), KRAS proto-oncogene, GTPase (Kras), Kirsten rat sarcoma viral oncogene homolog (Kras), semicolonial-7 (smco-7), Ras family protein (PGTG_03066), GTPase KRas (Tsp_02666), GTPase KRas (Tsp_01642), GTPase KRas (rask), Kirsten rat sarcoma viral oncogene homolog S homeolog (kras.S), AI929937, C-K-RAS, c-Ki-ras, CFC2, K-ras, k-ras, K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, Ki-ras, kras, Kras-2, kras-a, kras-b, KRAS1, Kras2, KRAS2, NS, NS3, p21, p21B, p21ras, ras, RASK2, rask2, wu:fa04e08, wu:fc14b12, wu:fc23g10, wu:fj89d12, zgc:85725Protein level used designations for K-RAS
- GTPase KRas
- fa04e08
- fc14b12
- fc23g10
- fj89d12
- xRAS2
- K-Ras 2
- Kirsten rat sarcoma viral oncogene homologue 2 (active)
- c-K-ras
- c-K-ras2 protein
- c-Kirsten-ras proto-oncogene
- ki-Ras
- v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
- K-ras p21 protein
- PR310 c-K-ras oncogene
- c-Ki-ras
- c-Kirsten-ras protein
- cellular c-Ki-ras2 proto-oncogene
- oncogene KRAS2
- transforming protein p21
- v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog
- Kirsten rat sarcoma oncogene 2, expressed
- p21 protein
- Kirsten rat sarcoma viral oncogene homolog S homeolog
- ras protein
- ras p21
- Kirsten rat sarcoma viral oncogene homolog
- Kirsten rat sarcoma viral (Kras-2) oncogene homolog